- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01885468
X-Ray Verified Accuracy of the proGAV Verification Instrument (X-AMIN)
January 26, 2017 updated by: Aesculap, Inc.
X-Ray Verified Accuracy of the Aesculap - Miethke proGAV Adjustable Shunt Pressure Setting Verification Instrument
This study is to verify the use of a hand held tool to verify the new setting of a hydrocephalus shunt (proGAV).
This tool would be used in place of an Xray of the patient's head, which is how settings are verified currently.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
12
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Madeira, California, United States, 93636-8762
- Valley Children's Hospital
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Hydrocephalus patients implanted with proGAV shunt requiring adjustment
Description
Inclusion Criteria:
- Implanted with proGAV Requiring adjustment Implant must be palpable under the skin
Exclusion Criteria:
- Unwilling to consent Implanted within 7 days of inclusion visit
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Level of agreement between the proGAV® verification instrument measurement and X-ray control measurements.
Time Frame: 1day
|
1day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
June 21, 2013
First Submitted That Met QC Criteria
June 21, 2013
First Posted (Estimate)
June 25, 2013
Study Record Updates
Last Update Posted (Estimate)
January 27, 2017
Last Update Submitted That Met QC Criteria
January 26, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAG-G-H-1106
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydrocephalus Shunt (proGAV) Requiring Adjustment
-
University Hospital, LinkoepingActive, not recruitingHydrocephalus, Normal Pressure | Ventriculomegaly, Cerebral | Shunt; Complications | Hydrocephalus AcquiredSweden
-
LifeBridge HealthUniversity Hospital, UmeåCompletedHydrocephalus | Shunt MalfunctionSweden
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanCompletedHydrocephalus | Ventriculoperitoneal Shunt Malfunction
-
NeuroDx DevelopmentBoston Children's HospitalUnknownCSF Flow Through the Shunt of a Hydrocephalus PatientUnited States
-
Sohag UniversityNot yet recruitingHydrocephalus | Shunt Malfunction
-
University Hospital, Basel, SwitzerlandRecruitingHydrocephalus | Ventriculoperitoneal Shunt (VPS)Switzerland
-
Baiyun LiuRecruitingHydrocephalus | Ventriculoperitoneal ShuntChina
-
Unity Health TorontoCompletedReal Function Post Conversion From Prograf to Advagraf | Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversionCanada
-
University of ValenciaRecruitingSleep Apnea | Normal Pressure Hydrocephalus | Cerebrospinal Fluid Shunt OcclusionSpain
-
University of ValenciaRecruitingCerebrospinal Fluid Levels of Amyloid Beta 1-42, H-tau and Phospho-tau Proteins | Cognitive Impairment and Its Evolution After Hydrocephalus Treatment | Motor Impairment and Its Evolution After Hydrocephalus Treatment | Ventricular Size and Its Evolution After Implantation of a Ventriculoperitoneal...Spain